Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
02/2003
02/19/2003EP1283831A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/19/2003EP1283828A1 Novel polymorph v of torasemide
02/19/2003EP1283827A2 Caspase inhibitors and uses thereof
02/19/2003EP1283823A1 Novel mmp-2/mmp-9 inhibitors
02/19/2003EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
02/19/2003EP1283721A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
02/19/2003EP1283710A1 Use of a celecoxib composition for fast pain relief
02/19/2003EP1283706A1 Dosage of transdermal delivery systems
02/19/2003EP1283699A2 Preparation of injectable suspensions having improved injectability
02/19/2003EP1283682A2 Tryptophan source from plants and uses therefor
02/19/2003EP1207878B1 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
02/19/2003EP1165559B1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
02/19/2003EP1119571B1 Tricyclic delta3-piperidines as alpha2-antagonists
02/19/2003EP1033131B1 Composition in the form of a drink having a delayed alcohol aversion effect
02/19/2003EP0994863B1 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
02/19/2003EP0920429B1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
02/19/2003EP0917530B1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
02/19/2003EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
02/19/2003EP0732926B1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors
02/19/2003CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives
02/19/2003CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative
02/19/2003CN1398188A Boltuminum toxin pharmaceutical compsns
02/19/2003CN1397557A NOvel octahydro-2H-pyridino-[1,2-a] pyrazine compound, its prepn. process and medicinal compound contg. them
02/19/2003CN1397554A Novel N-benzyl diethylenediamine compound, its prepn. process and medicinal compsns. contg. them
02/19/2003CN1397550A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them
02/19/2003CN1397547A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them
02/19/2003CN1397335A Application of dandelion herb in preparing medicines
02/19/2003CN1397324A Compound chinese medicine for treating cerebrovascular disease
02/19/2003CN1101698C Prepn. method of medicine for treating epilepsy
02/19/2003CA2420065A1 Methods for indentifying specifically cleavable peptides and use of such peptide sequences
02/18/2003US6521759 Aminothiazole inhibitors of cyclin dependent kinases
02/18/2003US6521754 Benzothiazole derivatives with activity as adenosine receptor ligands
02/18/2003US6521650 Amines as pharmaceutical agents
02/18/2003US6521640 Method for interviewing neuronal death using sulfasalazine
02/18/2003US6521639 Donepezil hydrochloride and lactate of a higher alcohol; increased absorption
02/18/2003US6521638 2,3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents)
02/18/2003US6521634 Uses of dl-THP
02/18/2003US6521630 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof
02/18/2003US6521606 Matrix metalloproteinase inhibitors
02/18/2003US6521456 Gene therapy for cancer; treating viral infections, nervous system disorders, graft rejection, and monogenic or polygenic disorders
02/18/2003US6521437 Human sphingosine lyase polypeptides
02/18/2003US6521417 Incubating permeabilized cells expressing mutant kinase with radiolabeled analog; cytolysis, separation by sodium dodecyl sulfate polyacrylamide gel electrophoresis
02/18/2003US6521414 Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1
02/18/2003US6521259 Controlled release material comprising polyanhydrides, copolymers of lactic acid and glycolic acid, polylactic acid, polyglycolic acid, polyesters, polyorthoesters, proteins, polysaccharides; ouabain, digoxin
02/18/2003CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
02/18/2003CA2073042C Phenylethanolamines, drugs containing these compounds, and a method of preparing them
02/16/2003CA2397698A1 Difluoromethylene aromatic ethers as inhibitors of glycine transport
02/15/2003CA2397371A1 Pharmaceutical combinations for the treatment of neurodegenerative diseases
02/15/2003CA2392309A1 Neuropeptide receptor and uses thereof
02/15/2003CA2392305A1 Adrenic acid receptor and uses thereof
02/13/2003WO2003012441A1 Method for detecting modulators of notch signalling
02/13/2003WO2003012137A2 Methods for detecting parkinson's disease
02/13/2003WO2003012111A2 Conjugates for the modulation of immune responses
02/13/2003WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof
02/13/2003WO2003012093A2 Regulator of calcineurin
02/13/2003WO2003012089A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
02/13/2003WO2003012045A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
02/13/2003WO2003011906A2 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
02/13/2003WO2003011892A2 Glp-1 exendin-4 peptide analogs and uses thereof
02/13/2003WO2003011881A2 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain
02/13/2003WO2003011873A2 Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
02/13/2003WO2003011870A1 Gonadotropin-releasing hormone receptor antagonists
02/13/2003WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
02/13/2003WO2003011864A1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS
02/13/2003WO2003011863A1 Novel crystal forms of 9-substituted hypoxanthine derivatives
02/13/2003WO2003011860A2 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
02/13/2003WO2003011858A1 Substituted isoindoles and e use thereof
02/13/2003WO2003011856A1 Aminoalkylimidazole derivatives preparation and therapeutic use thereof
02/13/2003WO2003011855A2 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003WO2003011846A2 Process for the preparation of 5-substituted isobenzofurans
02/13/2003WO2003011843A1 Novel 2,4-diaminothiazole derivatives
02/13/2003WO2003011841A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists
02/13/2003WO2003011839A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
02/13/2003WO2003011831A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
02/13/2003WO2003011830A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
02/13/2003WO2003011828A2 3-pyridylether rerivatives and their use as analgesics
02/13/2003WO2003011823A2 Crfr1 selective ligands
02/13/2003WO2003011810A1 Method for the nitration of phenolic compounds
02/13/2003WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
02/13/2003WO2003011396A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines
02/13/2003WO2003011317A1 Modulators of notch signalling for use in immunotherapy
02/13/2003WO2003011314A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity
02/13/2003WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity
02/13/2003WO2003011300A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness
02/13/2003WO2003011293A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
02/13/2003WO2003011290A1 Methods for inhibiting or reversing tau filament formation polymerization
02/13/2003WO2003011289A1 Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines
02/13/2003WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists
02/13/2003WO2003011287A1 Pyrazolon derivatives as inhibitors of gsk-3
02/13/2003WO2003011284A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity
02/13/2003WO2003011281A1 Treatment of attention deficit hyperactivity disorder or attention deficit disorder
02/13/2003WO2003011278A1 Crystalline composition containing escitalopram
02/13/2003WO2003011276A1 Nf?b inhibitor
02/13/2003WO2003011272A1 Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines
02/13/2003WO2003011270A1 Agent for treating depressive disorders containing a local anesthetic agent
02/13/2003WO2003011269A1 Agent for treating the symptoms of dementia disorders containing an additional local anesthetic agent
02/13/2003WO2003011268A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
02/13/2003WO2003011264A2 Betacarboline derivatives as gaba a-receptor-modulators having nmda-antagonistic activity for treating diseases of the central nervous system
02/13/2003WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes
1 ... 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 ... 1833